Pro Health Tips
Friday, 1 January 2021
Trial Of Novavax COVID-19 Vaccine Begins In The United States
Phase 3 clinical trial of the COVID-19 vaccine NVX-CoV2373 developed by Novavax will begin in the United States and Mexico and enroll 30,000 participants.
from Medindia Health News https://ift.tt/3rN8Vqw
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
Phase 3 clinical trial of the COVID-19 vaccine NVX-CoV2373 developed by Novavax will begin in the United States and Mexico and enroll 30,000 participants.
No comments:
Post a Comment